Protective effects of madecassoside against Doxorubicin induced nephrotoxicity in vivo and in vitro

Scientific Reports

Volumn 5, Issue , 2015, Pages

  Su, Zhonghao ^a,b   Ye, Jin ^b   Qin, Zhenxia ^b   Ding, Xianting ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC ANTIBIOTIC; ANTIOXIDANT; DOXORUBICIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MADECASSOSIDE; NITRIC OXIDE; PROTECTIVE AGENT; TRITERPENE;

ANIMAL; APOPTOSIS; BODY WEIGHT; CELL LINE; CELL SURVIVAL; CHEMISTRY; DRUG EFFECTS; KIDNEY; KIDNEY FUNCTION TEST; MALE; METABOLISM; MOUSE; NEPHRITIS; PATHOLOGY; PATHOPHYSIOLOGY; SIGNAL TRANSDUCTION;

ANIMALS; ANTIBIOTICS, ANTINEOPLASTIC; ANTIOXIDANTS; APOPTOSIS; BODY WEIGHT; CELL LINE; CELL SURVIVAL; DOXORUBICIN; KIDNEY; KIDNEY FUNCTION TESTS; MALE; MAP KINASE SIGNALING SYSTEM; MICE; NEPHRITIS; NF-KAPPA B; NITRIC OXIDE; PROTECTIVE AGENTS; TRITERPENES;

EID: 84950156773     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep18314     Document Type: Article

References (26)

1. Hashim, P. et al. Triterpene composition and bioactivities of Centella asiatica. Molecules 16, 1310-1322 (2011).
2. Song, J. et al. Madecassoside suppresses migration of fibroblasts from keloids: involvement of p38 kinase and PI3K signaling pathways. Burns: journal of the International Society for Burn Injuries 38, 677-684 (2012).
3. Cao, W. et al. Madecassoside suppresses LPS-induced TNF-alpha production in cardiomyocytes through inhibition of ERK, p38, and NF-kappaB activity. International immunopharmacology 10, 723-729 (2010).
4. Bian, G. X. et al. Madecassoside reduces ischemia-reperfusion injury on regional ischemia induced heart infarction in rat. Biol Pharm Bull 31, 458-463 (2008).
5. Li, H. et al. Madecassoside attenuates inflammatory response on collagen-induced arthritis in DBA/1 mice. Phytomedicine 16, 538-546 (2009).
6. Liu, M. et al. Anti-rheumatoid arthritic effect of madecassoside on type II collagen-induced arthritis in mice. Int Immunopharmacol 8, 1561-1566 (2008).
7. Chandran, K. et al. Doxorubicin inactivates myocardial cytochrome c oxidase in rats: cardioprotection by Mito-Q. Biophys J 96, 1388-1398 (2009).
8. Lefrak, E. A., Pitha, J., Rosenheim, S. & Gottlieb, J. A. A clinicopathologic analysis of adriamycin cardiotoxicity. Cancer 32, 302-314 (1973).
9. Elsherbiny, N. M. & El-Sherbiny, M. Thymoquinone attenuates Doxorubicin-induced nephrotoxicity in rats: Role of Nrf2 and NOX4. Chemico-biological interactions 223C, 102-108 (2014).
10. Singla, S., Kumar, N. R. & Kaur, J. In vivo Studies on the Protective Effect of Propolis on Doxorubicin-Induced Toxicity in Liver of Male Rats. Toxicology international 21, 191-195 (2014).
11. Simmons, T. W. & Jamall, I. S. Relative importance of intracellular glutathione peroxidase and catalase in vivo for prevention of peroxidation to the heart. Cardiovasc Res 23, 774-779 (1989).
12. Davies, K. J. & Doroshow, J. H. Redox cycling of anthracyclines by cardiac mitochondria. I. Anthracycline radical formation by NADH dehydrogenase. J Biol Chem 261, 3060-3067 (1986).
13. Wu, Y. et al. Multiplexed assay panel of cytotoxicity in HK-2 cells for detection of renal proximal tubule injury potential of compounds. Toxicol In Vitro 23, 1170-1178 (2009).
14. Luo, Y. et al. Neuroprotective effects of madecassoside against focal cerebral ischemia reperfusion injury in rats. Brain Res 1565, 37-47.
15. Park, E. J., Kwon, H. K., Choi, Y. M., Shin, H. J. & Choi, S. Doxorubicin induces cytotoxicity through upregulation of pERK-dependent ATF3. PloS one 7, e44990 (2012).
16. Carvalho, C. et al. Doxorubicin: the good, the bad and the ugly effect. Curr Med Chem 16, 3267-3285 (2009).
17. Lu, G. X. et al. Madecassoside ameliorates bleomycin-induced pulmonary fibrosis in mice by downregulating collagen deposition. Phytotherapy research: PTR 28, 1224-1231 (2014).
18. Lin, X. et al. Protective effect of madecassoside against cognitive impairment induced by D-galactose in mice. Pharmacology, biochemistry, and behavior 124, 434-442 (2014).
19. Ueno, M. et al. Doxorubicin induces apoptosis by activation of caspase-3 in cultured cardiomyocytes in vitro and rat cardiac ventricles in vivo. J Pharmacol Sci 101, 151-158 (2006).
20. Reubold, T. F. & Eschenburg, S. A molecular view on signal transduction by the apoptosome. Cellular signalling 24, 1420-1425 (2012).
21. Lin, H. et al. Peroxisomal proliferator-activated receptor-alpha protects renal tubular cells from doxorubicin-induced apoptosis. Mol Pharmacol 72, 1238-1245 (2007).
22. Rehman, M. U. et al. D-limonene suppresses doxorubicin-induced oxidative stress and inflammation via repression of COX-2, iNOS, and NFkappaB in kidneys of Wistar rats. Experimental biology and medicine 239, 465-476 (2014).
23. Johnson, G. L. & Lapadat, R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 298, 1911-1912 (2002).
24. Ibrahim, M. A. et al. Angiotensin-converting enzyme inhibition and angiotensin AT(1)-receptor antagonism equally improve doxorubicin-induced cardiotoxicity and nephrotoxicity. Pharmacol Res 60, 373-381 (2009).
25. Sarih, M., Souvannavong, V. & Adam, A. Nitric oxide synthase induces macrophage death by apoptosis. Biochem Biophys Res Commun 191, 503-508 (1993).
26. Hassan, M. H., Ghobara, M. & Abd-Allah, G. M. Modulator effects of meloxicam against doxorubicin-induced nephrotoxicity in mice. Journal of biochemical and molecular toxicology 28, 337-346 (2014).